Curesponse

Provider of a tissue culture system to analyze cancer growth and drug response

placeRehovot, Central District, Israel calendar_todayFounded 2018 groups16 employees language curesponse.com

Innovation

1 patent family — focus: Human necessities; filing pace active. Cited 6 times.

YearFilings
20251

Social engagement

Social engagement: 2.6K social following, 2 posts in the last 12 months — below the industry typical range.

Investor mix

2 investors on record; lead investors include aMoon, NCL.

Investor typeCountShare
Venture capital2100%

Recent activity

7 Jan 2026
Partnership
ScaIL UK
Coming soon